AlphAIalphai — Financial news for AI agents
StockHealthcare · Drug Manufacturers - Specialty & Generic

$COLL

COLLEGIUM PHARMACEUTICAL, INC

Price · $COLLvia TradingView
AI sentiment · 7d1 articles
MAY 22net (bullish − bearish)MAY 28
Bullish
1
Neutral
0
Bearish
0
Insider · 30dFeed →

No SEC Form 4 filings for $COLL in the last 30 days.

Top stories · $COLLMore →
MAY 27·finance.yahoo.comHigh

Why Collegium Pharmaceutical Inc. (COLL) Stock Is Gaining Attention for Its ADHD Portfolio

Collegium Pharmaceutical (NASDAQ:COLL) reported Q1 2026 results on May 7, with revenue up 9% YoY to $193.5 million, beating the Street’s $187.4 million estimate. Adjusted EPS rose to $1.76 from $1.49 and topped expectations of $1.63. The company cited strong ADHD franchise growth, including Jornay PM sales up 36% YoY, and expects Jornay PM revenue of $190–$200 million in 2026. Collegium also plans to expand its ADHD portfolio via Azstarys acquisition, expecting it to add over $50 million to H2 2

MAY 19·Stock Titan

Collegium Pharmaceutical (COLL) director Donovan Glancy files initial Form 3

Collegium Pharmaceutical (COLL) director Donovan Michael Glancy has filed an initial Form 3, indicating his start as a reporting person for the company. This filing discloses his initial ownership of Collegium Pharmaceutical securities but does not report any transactions or derivative positions. A Form 3 is a mandatory SEC filing for new insiders, establishing a baseline for their holdings.

MAY 19·Stock Titan

Director Carlos V. Paya granted 8,741 RSUs at COLLEGIUM (NASDAQ: COLL)

COLLEGIUM PHARMACEUTICAL, INC. director Carlos V. Paya was granted 8,741 restricted stock units (RSUs) as compensation, increasing his direct holdings to 28,323 shares. These RSUs will vest on the earlier of May 14, 2027, or the company's 2027 Annual Meeting of Shareholders, contingent on his continued board service. The grant price was $0.00, and the settlement will be in common stock shares upon vesting or under specific conditions like the end of his board service or a change in control.

News on $COLL